Gene and protein expression analyses in lymphocytes and cancer samples after DC vaccination identified vital immunoregulatory pathways, including PD-1 and CTLA-4, which correlated with inferior clinical outcomes [379]. This evidence concerns the gene CTLA4 and cancer.